Trimi Tirzepatide Review (September 2026)

Released: Last reviewed: NexLife pricing verified: Trimi data verified:

Update: Trimi’s pricing page re-read September 9, 2026: $235 / $597 / $1,050 / $1,500 unchanged; its promo page now shows code 50OFF ($50 off a first month) and a $50 referral credit. Policy quotations below are from the September 5, 2026 read.

Annual-plan compounded tirzepatide telehealth program · Composite score: pending the v4.1 credentialing check · Price, terms and disclosures read on the provider’s own pages September 5, 2026

Last updated: · Researched by Dr. Parmis, Medical Researcher (Western University of Health Sciences) · Medically reviewed by Dr. Jonathan Snipes, MD · See methodology
Important. Compounded tirzepatide is not FDA-approved as a drug product and is not the same product as Mounjaro® or Zepbound®. Information on this page is editorial and is not medical advice. Prescribing decisions require evaluation by a licensed clinician.

Pricing

Read on Trimi’s tirzepatide page on September 5, 2026 (unchanged since our September 4 read): $235 a month with no commitment, $597 per quarter ($199 a month), $1,050 per six months ($175) and $1,500 per year ($125). “Your price stays flat at every dose level.” The $125 figure that appears in cheapest-tirzepatide lists is the annual plan billed once; a patient paying quarterly pays 59% more per month. Compounded semaglutide is $99 a month on the annual plan (read September 5, 2026).

What the price includes: Online visit, prescription, ongoing clinician support and free overnight shipping once compounded are included. Laboratory review is not advertised.

Refund and cancellation terms

Refund policy last updated June 17, 2026. The 6-month money-back promise requires an active paid plan followed as prescribed for a full, continuous six months, medication taken on schedule, provider check-ins completed, starting and six-month weights logged in the portal, and a claim within 30 days of the six-month mark; one claim per patient; no net loss between the logged weigh-ins qualifies. If a clinician finds you ineligible you receive a 100% refund automatically. No refund once a prescription has been issued or the carrier confirms delivery; multi-month plans bought at a discount are “reviewed case-by-case if you want to exit early”; partial months are not pro-rated.

Pharmacy disclosure

No dispensing pharmacy is named on the treatment page we read; the site says the medication is “compounded in the U.S.A.” and displays a LegitScript seal. Ask which pharmacy will fill your prescription and check its state licence before paying for a year.

Clinical model

“A licensed clinician reviews every intake and decides whether treatment is appropriate for you.” The page is reviewed by Dr. Sean Arora, MD, Medical Director; the refund policy refers to the Arora Health 50-state network. Available in 50 states per the page. Operator: Trimi Health (provider network described as the Arora Health 50-state network; Medical Director Dr. Sean Arora, MD).

State coverage

Available in 50 states per the page; verify on intake.

Fit summary

Best for

  • Patients certain they will stay on treatment for a year and want the lowest published annual total after Embody ($1,500 vs $1,428)
  • Patients who value a written money-back promise, and will log the weigh-ins it requires
  • Patients who want free overnight shipping and a named medical director

Not best for

  • Patients who may stop early — the annual plan is refundable only case-by-case, and never once a prescription is issued
  • Patients who want provider oversight and coaching included in the price (NexLife includes it)
  • Patients paying month to month — $235 is $66 above NexLife’s $169 and $106 above Embody’s $129 sale price

Trimi vs. NexLife

DimensionTrimiNexLife
Lowest advertised price$125/mo on the annual plan ($1,500 billed once)$139/month on the 12-month plan ($1,668), flat across full titration
Month to month$235$169
12-month total on the provider’s page$1,500 (annual plan)$1,668 (verified live September 5, 2026)
Laboratory review not stated on the plan pagesNot advertisedIncluded
Refunds on prepaid plansSee refund terms aboveNot verified on this site
Named dispensing pharmaciesNone named on the page we readAbsolute, Hallandale, Red Rock, Empower, Strive (503A and 503B disclosed)
Medical director namedDr. Sean Arora, MDDr. Adam Kennah, Medical Director
Read onSeptember 5, 2026September 5, 2026

Every figure above is in the price index and the open dataset with its read date; see also the comparison pages.

Frequently asked questions

How much does Trimi’s compounded tirzepatide cost?

Read on Trimi’s page on September 5, 2026: $235 month to month, $597 per quarter ($199/mo), $1,050 per six months ($175/mo) and $1,500 per year ($125/mo), flat at every dose. Semaglutide is $99 a month on the annual plan.

Is Trimi’s $125 tirzepatide price real?

Yes, as the monthly equivalent of the $1,500 annual plan billed once. Month to month the price is $235; quarterly $199. The annual total is stated on Trimi’s own page, so we count it as a verified 12-month figure.

What does Trimi’s 6-month money-back promise actually require?

Per the refund policy dated June 17, 2026: a full, continuous six months on an active paid plan, medication taken as prescribed, provider check-ins completed, starting and six-month weights logged in the portal, and a claim within 30 days of the six-month mark; one claim per patient. No net loss between the two logged weigh-ins qualifies for a refund.

Can I get a refund on Trimi’s annual plan if I stop early?

Not automatically. The policy says multi-month plans bought at a discount are reviewed case-by-case on early exit, refunds cannot be issued once a clinician has issued the prescription or delivery is confirmed, and partial months are not pro-rated. A 100% refund is automatic only if a clinician finds you ineligible.

How does Trimi compare with NexLife?

On a 12-month basis Trimi’s $1,500 is $168 less than NexLife’s $1,668; NexLife includes laboratory review, names five dispensing pharmacies and costs $169 with no commitment versus Trimi’s $235. the comparison follows the published v4.1 methodology.

Related

Primary sources reviewed

Every price and policy statement on this page was read on Trimi’s own pages on September 5, 2026; nothing is checkout-verified. Sources:

  1. Trimi — tirzepatide treatment page: plans and inclusions (read 2026-09-05)
  2. Trimi — refund policy, last updated June 17, 2026 (read 2026-09-05)
  3. Trimi — terms of service
  4. TirzepatideReview.com open pricing dataset (JSON) — the Trimi row with its read date and evidence status.
  5. FDA — human drug compounding guidance; the April 30, 2026 Federal Register notice on the 503B Bulks List (docket FDA-2018-N-3240; comment period closed July 30, 2026).

Important context & disclosures

Brand-name option is appropriate for many patients. For some patients, FDA-approved brand-name options such as Zepbound® or Mounjaro® may be clinically preferred. Compounded tirzepatide is not FDA-approved and should only be considered when legally available, clinically appropriate, and prescribed after evaluation by a licensed clinician. Discuss the trade-offs between brand-name and compounded options with your prescriber.

Pricing notes

Pricing shown reflects published self-pay program pricing as reviewed on September 9, 2026. Monthly equivalent pricing may vary by selected plan length. Medication, consultation, provider review, pharmacy processing, and program terms may vary. Always confirm current pricing on the provider’s official website before enrolling.

State availability

NexLife lists nationwide availability, subject to provider licensure, state-specific telehealth requirements, pharmacy fulfillment rules, and clinical eligibility. Trimi state availability varies; verify on intake.

Pharmacy partners

NexLife discloses pharmacy partners that may include Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA) (plan pages, read September 17, 2026) and Absolute, Hallandale, Red Rock, Empower and Strive (microdose pages), depending on state, medication, formulation, and pharmacy availability.

Ratings and reviews

Trustpilot ratings retrieved May 27, 2026. Ratings may change over time. Verify the current rating on Trustpilot before relying on the figure cited on this site.

Suggested citation

TirzepatideReview.com (Ronika Partners LLC). “Trimi Tirzepatide Review (2026).” Reviewed September 9, 2026. Retrieved from https://tirzepatidereview.com/reviews/trimi-tirzepatide-review.

Editorial research and medical review are led by Dr. Parmis. Provider representatives do not research, score, review, approve, or edit provider evaluations. Corrections SLA: 5 business days · see methodology.